Celldex Therapeutics (CLDX) Q3 2022 Earnings

8AugConfirmed
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.59
-0.51
-0.43
-0.35

Details

Expected EPS
-0.51
Actual EPS
-0.59
Surprise EPS
-0.08
Surprise Percent
+15.69%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.59 per share for Q3 2022.

0 Comments

Share your thoughts